A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid

被引:293
作者
Moore, KJ
El Khoury, J
Medeiros, LA
Terada, K
Geula, C
Luster, AD
Freeman, MW
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA
[4] Beth Israel Deaconess Med Ctr, Div Aging, Boston, MA 02114 USA
关键词
D O I
10.1074/jbc.M208788200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Amyloid accumulation is associated with pathologic changes in the brain in Alzheimer's disease and has recently been identified in plaques of another chronic inflammatory disorder, atherosclerosis. The class B scavenger receptor, CD36, mediates binding of fibrillar beta-amyloid to cells of the monocyte/macrophage lineage, including brain macrophages (microglia). In this study, we demonstrate that in microglia and other tissue macrophages, beta-amyloid initiates a CD36-dependent signaling cascade involving the Src kinase family members, Lyn and Fyn, and the mitogen-activated protein kinase, p44/42. Interruption of this signaling cascade, through targeted disruption of Src kinases downstream of CD36, inhibits macrophage inflammatory responses to beta-amyloid, including reactive oxygen and chemokine production, and results in decreased recruitment of microglia to sites of amyloid deposition in vivo. The finding that engagement of CD36 by beta-amyloid initiates a Src kinase-dependent production of inflammatory mediators in cells of the macrophage lineage reveals a novel receptor-mediated pro-inflammatory signaling pathway of potential therapeutic importance.
引用
收藏
页码:47373 / 47379
页数:7
相关论文
共 30 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   Inflammatory mechanisms in Alzheimer's disease:: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists [J].
Combs, CK ;
Johnson, DE ;
Karlo, JC ;
Cannady, SB ;
Landreth, GE .
JOURNAL OF NEUROSCIENCE, 2000, 20 (02) :558-567
[3]  
Combs CK, 2001, J NEUROSCI, V21, P1179
[4]  
Combs CK, 1999, J NEUROSCI, V19, P928
[5]   CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils [J].
Coraci, IS ;
Husemann, J ;
Berman, JW ;
Hulette, C ;
Dufour, JH ;
Campanella, GK ;
Luster, AD ;
Silverstein, SC ;
El Khoury, JB .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) :101-112
[6]   Platelet phagocytosis and processing of β-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis [J].
De Meyer, GRY ;
De Cleen, DMM ;
Cooper, S ;
Knaapen, MWM ;
Jans, DM ;
Martinet, W ;
Herman, AG ;
Bult, H ;
Kockx, MM .
CIRCULATION RESEARCH, 2002, 90 (11) :1197-1204
[7]   Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease [J].
El Khoury, J ;
Hickman, SE ;
Thomas, CA ;
Loike, JD ;
Silverstein, SC .
NEUROBIOLOGY OF AGING, 1998, 19 (01) :S81-S84
[8]  
ElKhoury J, 1996, NATURE, V382, P716
[9]  
ENDEMANN G, 1993, J BIOL CHEM, V268, P11811
[10]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056